fda advisory committee to consider tofersen
Published 1 year ago • 377 plays • Length 27:23Download video MP4
Download video MP3
Similar videos
-
2:39
oral testimony to the fda advisory committee on the approval of tofersen
-
30:04
why fda decision on tofersen matters
-
57:05
tofersen and the fda approval process
-
7:09
als drug fails to win recommendation from fda advisory panel
-
6:03
fda advisory committee: ingredient in common decongestant ineffective
-
26:40
a psychedelic psychotherapist's thoughts on the fda advisory committee's mdma recommendations.
-
7:26:41
june 10, 2024 meeting of the peripheral and central nervous system drugs advisory committee (pcns)
-
7:04:21
june 9, 2023 meeting of the peripheral and central nervous system drugs advisory committee (pcns)
-
2:45
oral testimony by dr. senda ajroud-driss to the fda advisory committee meeting on tofersen
-
5:48
fda approves biogen’s tofersen drug for rare form of als
-
3:49
oral testimony to the fda advisory committee on the approval of amx0035
-
8:39:50
75th cellular, tissue, and gene therapies advisory committee
-
1:18:43
als fda session
-
8:30:00
august 2, 2024 meeting of the genetic metabolic diseases advisory committee (gemdac)
-
9:26:46
74th cellular, tissue, and gene therapies advisory committee
-
25:47
tofersen and the future of als drug development
-
6:04:50
oncologic drugs advisory committee meeting
-
3:01
fda advisory committee doctors discuss opioid labeling
-
2:47
fda advisory committee endorses third dose of moderna's covid-19 vaccine for specific groups
-
2:03:29
public meeting: optimizing fda’s use of and processes for advisory committees (morning portion)
-
1:32
tofersen (qalsody), first fda approved medication for sod1-als (amyotrophic lateral sclerosis)
-
3:14
fda advisory committee meets to discuss future of covid-19 boosters